Venclose RF Ablation System for the Treatment of IPVs

NACompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

May 23, 2020

Primary Completion Date

April 13, 2021

Study Completion Date

May 13, 2021

Conditions
Chronic Venous Insufficiency
Interventions
DEVICE

Radiofrequency (RF) Thermal Ablation of Incompetent Perforator Veins

The physician operator will access the IPV and advance the device to the target treatment position using ultrasound guidance. After providing local anesthesia to the vein and surrounding tissues, thermal ablation energy is delivered to the vein wall. After treatment is complete, the device is removed and vessel closure confirmed with duplex ultrasound.

Trial Locations (1)

75701

Vein Center of East Texas at CardioStream, Tyler

All Listed Sponsors
lead

Venclose, Inc.

INDUSTRY

NCT04386785 - Venclose RF Ablation System for the Treatment of IPVs | Biotech Hunter | Biotech Hunter